New River Pharmaceuticals Inc. situated at Radford in the State of Virginia or the United States, abbreviated as “NRPH” in the medical world. It’s the renowned pharmaceutical formulation company which has developed some marvelous prescription formulations in pharmaceuticals products accepted the world over. By implying its proprietary Carrierwave technology expertise NRPH is thriving by inventing advanced molecular entities that are plagiaristic of public usages.

Striving to introduce newer drugs: Company’s pilot product contending in scientific developments is Amphetamine Derivative and Opioid derivative is considered of offering superior substitutes of presently sold drugs. New drug for the treatment of typically persistent pains is already under preclinical designing and under extensive research stage. The preparation of such drug is anticipated to diminish development of opioid resistance along with such other drugs for the efficient treatment of hypothyroidism.

Technology: NRPH is determined of utilizing its Carrierwave technology in different ways for advancing the existing drugs by referring their Carrierwave technology compounds as Conditionally Bio-reversible Derivatives – CBDs. The company has developed the new molecule – “Derivative” prepared from the API – the Active Pharmaceutical Ingredients from the drug like Amphetamine or Opioid. NRPH has designed the pharmacologically inactive new molecules which gets activated or Bio-reversed only when taken as prescribed.

NRP-104: NRPH’s the most sophisticated compound formula is the CBD – Conditionally Bio-reversible Derivative of Amphetamine which is the established stimulant greatly used for the treatment of ADHD which is the extensively researched pediatric psychic disorder which has very recently been recognized in the adults also.